Novo Nordisk Back to the Office Amidst Job Cuts
Update: 2025-09-11
Description
Wegovy maker Novo Nordisk mandates a full return to the office for all employees amid job cuts and a $450 billion stock plunge, aiming to boost collaboration and decision-making as competition in the obesity drug market intensifies, sparking debate over work-life balance and echoing a growing trend among major employers to end remote work.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
